News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ROBINS HARLAN S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 354,610 shares
@ $0 |
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 3,700 shares
@ $32.05, valued at
$118.6k
Sold 300 shares
@ $31.36, valued at
$9.4k
Exercised 3,700 options to buy
@ $6.55, valued at
$24.2k
Exercised 300 options to buy
@ $6.55, valued at
$2k
|
|
| 10/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 68,681 shares
@ $0
Granted 171,703 options to buy
@ $43.68, valued at
$7.5M
|
|
| 02/05/2021 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 6,930 shares
@ $59.49, valued at
$412.3k
Sold 860 shares
@ $60.34, valued at
$51.9k
Exercised 7,790 options to buy
@ $6.32, valued at
$49.2k
|
|
| 02/03/2021 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 4,200 shares
@ $55.54, valued at
$233.3k
Sold 3,590 shares
@ $56.18, valued at
$201.7k
Sold 2,910 shares
@ $58.76, valued at
$171k
Sold 2,501 shares
@ $59.8, valued at
$149.6k
Sold 2,379 shares
@ $60.57, valued at
$144.1k
Exercised 7,790 options to buy
@ $6.32, valued at
$49.2k
Exercised 7,790 options to buy
@ $6.32, valued at
$49.2k
|
|
| 01/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 9,800 shares
@ $50.2, valued at
$492k
Sold 1,300 shares
@ $50.98, valued at
$66.3k
Sold 7,254 shares
@ $50, valued at
$362.7k
Sold 3,846 shares
@ $50.88, valued at
$195.7k
Sold 1,500 shares
@ $50.48, valued at
$75.7k
Sold 8,700 shares
@ $51.57, valued at
$448.7k
Sold 900 shares
@ $52.5, valued at
$47.3k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
|
|
| 10/20/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 11,100 shares
@ $51.79, valued at
$574.9k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
|
|
| 10/16/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 7,620 shares
@ $51.87, valued at
$395.2k
Sold 3,480 shares
@ $52.84, valued at
$183.9k
Sold 11,100 shares
@ $51.55, valued at
$572.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
|
|
| 09/24/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 7,000 shares
@ $47.34, valued at
$331.4k
Sold 4,100 shares
@ $47.95, valued at
$196.6k
Sold 11,100 shares
@ $48.16, valued at
$534.6k
Sold 3,640 shares
@ $46, valued at
$167.4k
Sold 3,560 shares
@ $47.28, valued at
$168.3k
Sold 3,900 shares
@ $47.98, valued at
$187.1k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
|
|
| 08/24/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 4,200 shares
@ $41.77, valued at
$175.4k
Sold 6,900 shares
@ $42.91, valued at
$296.1k
Sold 6,470 shares
@ $42.63, valued at
$275.8k
Sold 4,630 shares
@ $43.35, valued at
$200.7k
Sold 350 shares
@ $42.58, valued at
$14.9k
Sold 10,750 shares
@ $43.14, valued at
$463.8k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
|
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 1,500 shares
@ $46.21, valued at
$69.3k
Sold 9,600 shares
@ $46.95, valued at
$450.7k
Sold 8,277 shares
@ $45.72, valued at
$378.4k
Sold 2,823 shares
@ $46.38, valued at
$130.9k
Sold 700 shares
@ $45.36, valued at
$31.8k
Sold 6,657 shares
@ $46.84, valued at
$311.8k
Sold 3,743 shares
@ $47.25, valued at
$176.9k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
Exercised 11,100 options to buy
@ $6.32, valued at
$70.2k
|
|
| 05/21/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 38,628 shares
@ $40.11, valued at
$1.5M
Sold 31,372 shares
@ $40.48, valued at
$1.3M
|
|
| 05/18/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 3,200 shares
@ $34.26, valued at
$109.6k
Sold 28,000 shares
@ $35.44, valued at
$992.3k
Sold 100 shares
@ $33.56, valued at
$3.4k
Sold 400 shares
@ $35.13, valued at
$14.1k
Sold 5,400 shares
@ $36.34, valued at
$196.2k
Sold 22,342 shares
@ $37.53, valued at
$838.5k
Sold 7,158 shares
@ $38.11, valued at
$272.8k
Sold 600 shares
@ $38.67, valued at
$23.2k
Sold 10,500 shares
@ $39.36, valued at
$413.3k
Exercised 31,200 options to buy
@ $6.32, valued at
$197.2k
Exercised 35,400 options to buy
@ $6.32, valued at
$223.7k
|
|
| 04/22/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 2,000 shares
@ $27.72, valued at
$55.4k
Sold 7,912 shares
@ $28.63, valued at
$226.5k
Sold 4,988 shares
@ $29.58, valued at
$147.5k
Sold 1,203 shares
@ $28.55, valued at
$34.3k
Sold 2,697 shares
@ $29.5, valued at
$79.6k
Sold 100 shares
@ $29.63, valued at
$3k
Sold 25,500 shares
@ $30.28, valued at
$772.1k
Exercised 14,900 options to buy
@ $6.32, valued at
$94.2k
Exercised 3,900 options to buy
@ $6.32, valued at
$24.6k
Exercised 25,600 options to buy
@ $6.32, valued at
$161.8k
|
|
| 02/24/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 800 shares
@ $32.85, valued at
$26.3k
Sold 6,600 shares
@ $33.53, valued at
$221.3k
Exercised 7,400 options to buy
@ $6.32, valued at
$46.8k
|
|
| 02/20/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 18,500 shares
@ $31.38, valued at
$580.5k
Sold 3,500 shares
@ $32.18, valued at
$112.6k
Sold 3,900 shares
@ $33.21, valued at
$129.5k
Exercised 18,500 options to buy
@ $6.32, valued at
$116.9k
Exercised 7,400 options to buy
@ $6.32, valued at
$46.8k
|
|
| 02/18/2020 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 300,000 options to buy
@ $31.71, valued at
$9.5M
|
|
|
|
|